Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

537 results about "Molecular diagnostics" patented technology

Molecular diagnostics is a collection of techniques used to analyse biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. The technique is used to diagnose and monitor disease, detect risk, and decide which therapies will work best for individual patients.

RPA-Cas12a one-step detection system and application thereof

The invention relates to the field of molecular diagnosis, in particular to an RPA-Cas12a one-step detection system and application thereof. The invention finds that heparin sodium has cleavage activity for inhibiting LbCas12a, and develops a one-step nucleic acid detection method compatible with RPA amplification and Cas12 detection based on the inhibition effect. The detection limit of the method reaches 0.6 (copy / microliter), and the method can be expanded to other two Cas12 subtype proteins, namely AsCas12a and AapCas12b. In the detection of monkey pox virus, influenza A virus and new coronavirus as examples, compared with quantitative PCR, the detection sensitivity and specificity of the method both reach 95% or above. The CRISPR one-step nucleic acid detection method has the advantages of high sensitivity and specificity, short detection time and the like, and the potential nucleic acid aerosol pollution risk of a traditional two-step nucleic acid detection method is removed.
Owner:UNIV OF SCI & TECH OF CHINA

Marker for early diagnosis of sepsis-related diseases and application thereof

The invention belongs to the field of molecular diagnosis, and relates to a marker for early diagnosis of sepsis-related diseases and application thereof. The invention provides application of PAX5, or an active fragment and a functional fragment thereof in preparation of products for early diagnosis, risk assessment, immune state assessment, prognosis prediction and / or treatment scheme selection of sepsis-related diseases of an object. The PAX5 molecule is identified by utilizing various sequencing analysis means, detecting blood specimens of clinical infected patients and tracking clinical outcomes of the infected patients. The PAX5 has better diagnosis efficiency, and ROC analysis shows that AUC is 0.8, which exceeds the diagnosis efficiency of a clinical common index PCT. Therefore, the sepsis biomarker provided by the invention has great significance on clinical early-stage sepsis diagnosis and also has good application in the in-vitro diagnostic reagent industry.
Owner:CHENGDU CELENOV BIOTECH CO LTD

Auxiliary diagnosis method and system for bronchial asthma

The invention discloses an auxiliary diagnosis method and system for bronchial asthma, and relates to the technical field of molecular diagnosis prediction.The auxiliary diagnosis method comprises the steps that an experimental group and a control group are defined, and RNA of the experimental group and RNA of the control group are extracted for low-temperature preservation; carrying out quantitative PCR (Polymerase Chain Reaction) analysis on the RNA stored at low temperature and extracting target cDNA; collecting clinical data of the experimental group and calculating the corresponding biomarker concentration according to the target cDNA; and constructing a bronchial asthma prediction model, outputting a predicted risk probability value of each patient suffering from asthma, and dynamically classifying and adjusting the treatment schemes of the patients. RNA samples of an experimental group and a control group are accurately extracted and stored, remarkably changed gene expression is obtained in combination with quantitative PCR analysis, the gene expression is further combined with biomarker concentration, dynamic monitoring of the asthma-related inflammatory response is successfully achieved, and the bronchial asthma risk of a patient can be accurately evaluated by constructing a bronchial asthma prediction model. And a personalized treatment scheme is provided according to comprehensive analysis of gene expression and biomarkers.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE

Biomarker HLA-DOA for sepsis-related diseases and application of biomarker HLA-DOA

The invention belongs to the field of molecular diagnosis, and relates to a sepsis-related disease biomarker HLA-DOA and application thereof. The invention provides application of HLA-DOA or active fragments and functional fragments thereof in preparation of products for early diagnosis, risk assessment, immune state assessment, prognosis prediction and / or treatment scheme selection of sepsis-related diseases of an object. The biomarker HLA-DOA is identified by utilizing a plurality of sequencing analysis means, detecting blood samples of clinical infected patients and tracking clinical outcomes of the infected patients. The HLA-DOA is used for identifying common infection and sepsis and has high diagnostic efficiency, and ROC analysis shows that the AUC value of the HLA-DOA reaches 0.8954. Therefore, the sepsis biomarker provided by the invention has great significance on clinical early-stage sepsis diagnosis and also has good application in the in-vitro diagnostic reagent industry.
Owner:CHENGDU CELENOV BIOTECH CO LTD

Ammonia aromatic alkene modified near-infrared BODIPY fluorescent probe as well as preparation method and application thereof

The invention belongs to the technical field of organic synthesis, and particularly discloses an ammonia aromatic alkene modified near-infrared BODIPY fluorescent probe as well as a preparation method and application thereof.The near-infrared BODIPY fluorescent probe is obtained by adopting 6-(dimethylamino) nicotinic aldehyde to directionally modify the alpha position of BODIPY and constructing an expanded conjugated system through Knoevenagel condensation. Wherein dimethylamino provides a strong electron donating effect, a molecular structure is twisted into a non-planar configuration due to steric hindrance of a pyridine ring, pi-pi accumulation is reduced, and an ACQ effect is inhibited. According to the structural modification strategy, significant red shift of absorption / emission wavelength is realized by expanding a molecular pi-conjugated skeleton, and meanwhile, the stability of the BODIPY core and the quantum yield are effectively enhanced. The probe molecule can specifically recognize the diphenylalanine dipeptide structural unit by utilizing the synergistic coordination effect of the 2-aminopyridine derivative and the BODIPY mother nucleus, so that the selective detection of the Alzheimer's disease biomarker Abeta42 is realized, and a novel optical detection tool is provided for the early molecular diagnosis and targeted therapy of AD (Alzheimer's disease).
Owner:HUAIYIN INSTITUTE OF TECHNOLOGY

Apparatus and methods for molecular diagnostics

This disclosure relates to apparatus and methods for molecular diagnostics. Certain embodiments include a piston cycled from a first position proximal to a first end of a housing, to a second position proximal to a second end of the housing, and back to the first position proximal to the first end of the housing. In some embodiments, the present disclosure relates to devices, methods, and systems for molecular diagnostics that do not comprise a piston.
Owner:NUCLEIN LLC

Pressing and sealing apparatus for POCT kit, and molecular diagnostic device and operation method

The present invention relates to the technical field of medical instruments, and relates to the technical field of small amplification devices, especially portable amplification devices. Disclosed are a pressing and sealing apparatus for a POCT kit, and a molecular diagnostic device and operation method. The pressing and sealing apparatus for a POCT kit comprises a movable bracket, wherein a transmission assembly can drive the movable bracket to enable a sealing portion to seal a reaction chamber of the POCT kit when the movable bracket moves in a first direction; and when the transmission assembly drives the movable bracket to move in a second direction, a pressing portion comes into contact with the reaction chamber of the POCT kit to enable the reaction chamber of the POCT kit to tightly fit with a heat source. In the molecular diagnostic device including the pressing and sealing apparatus, a valve control portion and a clamping device share a second drive motor, a hot-melt bonding portion of the sealing portion and a detection and acquisition unit of the pressing portion share a first drive motor, a gas source drive part and a clamping apparatus cooperate with each other to drive liquid to flow through chambers of the kit, thereby achieving high integration, few drive parts, reliable operation, high detection accuracy, and small contamination.
Owner:XIAN TIANLONG SCI & TECH +1

Systemic lupus erythematosus molecular diagnosis marker based on neutrophil characteristics

The invention discloses a systemic lupus erythematosus molecular diagnosis marker based on neutrophil characteristics. The invention provides application of a substance for detecting the expression quantity of an IFIH1 gene and / or a CFLAR gene in preparation of a product for auxiliary diagnosis or screening or auxiliary screening of systemic lupus erythematosus. The invention also provides an application of a substance for detecting the relative expression quantity of the IFIH1 gene and the CFLAR gene and a carrier loaded with the following combined index C value model formula in preparation of a product for auxiliary diagnosis or screening or auxiliary screening of systemic lupus erythematosus. The specific gene expression marker IFIH1 and / or CFLAR of the neutrophile granulocyte is selected by focusing the unique change of the SLE neutrophile granulocyte to assist the clinical early-stage identification and diagnosis of the SLE, and an IFIH1 and CFLAR combined diagnosis model is constructed, so that the diagnosis or screening of the SLE is realized; the kit has high sensitivity and specificity.
Owner:BEIJING HOSPITAL

Heat-resistant MMLV reverse transcriptase and application thereof

The invention belongs to the technical field of molecular biology, and particularly discloses heat-resistant MMLV reverse transcriptase and application thereof. According to the heat-resistant MMLV reverse transcriptase provided by the invention, T246K mutation is introduced into a DNA polymerase active structural domain of a wild type MMLV reverse transcriptase, so that the heat stability and reverse transcription activity of the enzyme are remarkably improved. E286R, E302K and / or L435R mutations are further introduced into a thumb domain and a connecting structural domain, and the heat resistance of the enzyme can be improved by cooperating with T246K mutations. Meanwhile, D524G, E562Q and / or D583N mutations are introduced into an RNase H active structural domain, so that the RNase H activity of the enzyme can be reduced or removed. Compared with a commercial enzyme, the heat-resistant MMLV reverse transcriptase has the optimal reaction temperature higher than 50 DEG C, is suitable for high-temperature reverse transcription reaction, and has wide application prospects and higher economic value in the fields of molecular diagnosis and medical examination.
Owner:ZHENGZHOU MATERIS BIOTECHNOLOGY CO LTD

Method for molecular diagnosis of rare molecular subtypes of gastrointestinal stromal tumors (GIST)

The present invention relates to a method for the ex vivo molecular diagnosis of gastrointestinal stromal tumors, comprising the steps of: providing at least one isolated tissue sample comprising at least one nucleic acid and the subsequent extraction of the at least one nucleic acid. The method according to the present invention further comprises a step of quantifying the at least one previously isolated nucleic acid. Furthermore, the method according to the present invention comprises preparing at least one amplicon library of said previously isolated nucleic acid, which comprises sequences obtained from the FGFR1, NF1, SDHA, SDHB, SDHC and SDHD genes. This step is followed by the step of purifying the at least one amplicon library and the step of simultaneously sequencing the amplicons themselves. The present invention also relates to a multi-gene panel for ex vivo molecular diagnosis of gastrointestinal stromal tumors and a kit comprising such a panel.
Owner:ALMA MATER STUDIORUM UNIV DI BOLOGNA

At-Home Covid Nucleic Acid Detection Kit for Rapid Molecular Diagnostics

The present invention describes kits and methods for rapid detection of nucleic acid sequences in real-time and in any setting. Unique features of this kit include isothermal nucleic acid extraction in Unit 1, and amplification, labeling, and signal detection in Unit 2 (FIG. 1). These units can be operated separately with manual transfer of product from one to the other or can be put together in a fashion where user places sample into inlet of Unit 1 and observes results in detection chamber of Unit 2. Several versions of this kit can be developed using different sequence-specific primers and probes to detect any nucleic acid sequence (DNA or RNA) in a multiplex fashion. In a preferred embodiment, visual detection of amplified signal is done using Lateral Flow Strips, eliminating the need for any additional complex equipment. Such a kit can be easily developed and manufactured to assist in the mitigation response to any pandemic, especially for COVID-19. The COVID-19 kit is called an At-Home COVID test (AH-COV).
Owner:ABBUD ANTAKI RULA

Virus nucleic acid variation amplification-free LSPR detection method and chip based on gold nanostructure

The invention relates to the technical field of crossing of biomedical engineering, molecular diagnosis and nano-optical sensing, and particularly discloses a virus nucleic acid variation amplification-free LSPR (Local Surface Plasmon Resonance) detection method and chip based on a gold nano-structure. The virus nucleic acid variation amplification-free LSPR detection chip based on the gold nanostructure comprises a sample injection port, a reaction area, a washing area, a detection area and a waste liquid area, the sample injection port is used for injecting a viral nucleic acid or protein sample, a plurality of groups of probe sequences are fixed in different reaction regions of the chip, non-amplification rapid detection of viral nucleic acid variation is realized, high sensitivity and specificity are ensured, and by utilizing the unique advantages of an MSNs template branched gold nanostructure, the detection sensitivity is improved. Refractive index change caused by single base mutation is directly amplified, the capability of completing femtomole-level detection within 30 minutes is achieved, the overall detection speed is increased, rapid typing detection of viral nucleic acid variation is achieved through LSPR spectral signals under the non-amplification condition, and a portable platform is formed by integrating the LSPR spectral signals and a micro-fluidic chip.
Owner:HARBIN INSTITUTE OF TECHNOLOGY (SHENZHEN) (INSTITUTE OF SCIENCE AND TECHNOLOGY INNOVATION HARBIN INSTITUTE OF TECHNOLOGY SHENZHEN)

Biomarker HLA-DQA for sepsis-related diseases and application of biomarker HLA-DQA

The invention belongs to the field of molecular diagnosis, and relates to a sepsis-related disease biomarker HLA-DQA and application thereof. The invention provides application of HLA-DQA or active fragments and functional fragments thereof in preparation of products for early diagnosis, risk assessment, immune state assessment, prognosis prediction and / or treatment scheme selection of sepsis-related diseases of an object. The biomarker HLA-DQA is identified by utilizing a plurality of sequencing analysis means, detecting blood samples of clinical infected patients and tracking clinical outcomes of the infected patients. The HLA-DQA is used for identifying common infection and sepsis and has high diagnostic efficiency, and ROC analysis shows that the AUC value of the HLA-DQA reaches 0.8988. Therefore, the sepsis biomarker provided by the invention has great significance on clinical early-stage sepsis diagnosis and also has good application in the in-vitro diagnostic reagent industry.
Owner:CHENGDU CELENOV BIOTECH CO LTD

Novel thin film material for molecular diagnosis nascent biosensor, thin film transistor and preparation method and application of novel thin film material and thin film transistor

The invention relates to the technical field of biosensors, in particular to a novel thin film material for a molecular diagnosis nascent biosensor, a thin film transistor and a preparation method and application of the novel thin film material and the thin film transistor. The thin film transistor is prepared from a novel thin film material, the thin film material covers the surface of a substrate of the transistor, and a source electrode and a drain electrode of the transistor are arranged between the substrate and a thin film in parallel. The concentration of the cancer marker is detected by monitoring the variable quantity of threshold voltage (Vth) in a transfer curve of the organic-inorganic hybrid thin film transistor, the responsivity and sensitivity to a disease marker are improved by optimizing a semiconductor material combination, efficient detection of the low-concentration cancer marker is realized, and the method has the characteristics of no label, rapidness, simplicity and convenience, and is suitable for popularization and application. The kit is suitable for early diagnosis of diseases.
Owner:TIANJIN UNIVERSITY OF TECHNOLOGY

Method and kit for eliminating false positive result in nucleic acid amplification reaction

The invention belongs to the field of nucleic acid detection and molecular biology, and particularly relates to a method and a kit for eliminating false positive results in nucleic acid amplification reaction. According to the method, after a nucleic acid amplification reaction (taking recombinase polymerase amplification, namely RPA, for example) is completed, a target amplification product is subjected to selective enzyme digestion by utilizing restriction endonuclease, non-target products (such as primer dimers and non-specific amplification products) are not cut, and meanwhile, the non-target products which are not subjected to enzyme digestion are removed by combining solid-phase separation, so that the target amplification product is obtained. Therefore, the false positive result is eliminated. The invention also discloses a kit containing the restriction enzyme. According to the method, the specificity and the signal-to-noise ratio of a nucleic acid amplification reaction, especially RPA, are remarkably improved, the cost is low, operation is easy, the method is compatible with an existing technical platform, the method is suitable for detection scenes such as clinical molecular diagnosis, environmental monitoring and food safety, and the problem of misjudgment caused by false positive signals is effectively avoided.
Owner:SICHUAN UNIV

Nucleic acid detection consumable processing module, detection system and use method

The invention discloses a nucleic acid detection consumable processing module, a detection system and a use method, and belongs to the field of medical examination and inspection instruments and molecular diagnosis and detection instruments, the technical key points are that the nucleic acid detection consumable processing module comprises a driving module, a temperature control and clamping integrated module, an L-shaped consumable lifting bracket and a flip module; and the driving module is used for driving the temperature control and clamping integrated module to clamp / loosen a detection chip of the consumable, driving the L-shaped consumable lifting bracket to ascend / descend and driving the flip module to rotate at the same time. The invention aims to provide the nucleic acid detection consumable processing module, the detection system and the use method, and the operation of sample processing and detection is simplified.
Owner:SUZHOU MOLARRAY CO LTD

Exosome small non-coding RNA molecule marker and application thereof

The application discloses an exosome small non-coding RNA molecule marker and application thereof, and belongs to the field of tumor liquid biopsy and molecular diagnosis. The exosome small non-coding RNA molecule marker is at least one of tRNA-GlyGCC-5 and sRESE; the nucleotide sequence of the tRNA-GlyGCC-5 is shown as SEQ ID NO:1; and the nucleotide sequence of the sRESE is shown as SEQ ID NO:2. The sRESE in the application is a brand new small non-coding RNA sequence, and is first discovered by the inventor, which is important for the marker of esophageal cancer and the research on disease progression mechanism. The tumor diagnosis kit provided by the application, which comprises the exosome small non-coding RNA molecule marker, is a liquid diagnosis monitoring kit with non-invasiveness, high sensitivity, high specificity and applicability to general survey or screening.
Owner:JINAN UNIVERSITY

Molecular diagnostic devices and methods for retaining and mixing reagents

A molecular diagnostic test device can include a housing and a sample preparation module within the housing. The sample preparation module defines an input reservoir and a sample input opening through which a biological sample can be loaded into the input reservoir. The sample preparation module includes a solid reagent contained within the input reservoir. The molecular diagnostic test device can include a fluid source within the housing. The fluid source is in fluid communication with the input reservoir such that upon activation of the molecular diagnostic test device, the fluid from the fluid source is injected into the input reservoir to mix the biological sample and the solid reagent within the input reservoir to form an input solution containing a target molecule.
Owner:VISBY MEDICAL INC

Rapid culture system and culture method of mycoplasma pneumoniae

The invention discloses a rapid culture system of mycoplasma pneumoniae. The rapid culture system comprises a growth-promoting additive A, a growth-promoting additive B and a growth-promoting additive C, wherein the growth-promoting additive A is A549 cell lysis buffer; the growth promoting additive B is a mixture of deoxyribonucleoside triphosphate and / or ribonucleoside triphosphate. The rapid culture system can promote rapid growth and reproduction of the mycoplasma pneumoniae, fully meets the nutritional requirements and growth requirements of the mycoplasma pneumoniae, and is of great significance to isolated culture, enrichment culture, epidemic disease prevention and control and molecular diagnosis of the mycoplasma pneumoniae. The invention also provides a culture method of the mycoplasma pneumoniae. The invention also provides application of the rapid culture system of the mycoplasma pneumoniae in in-vitro cell culture of the mycoplasma pneumoniae.
Owner:SOUTHWEST MEDICAL UNIV

MiRNA combination and kit for assisting stage screening of hepatic fibrosis and use method of miRNA combination and kit

The invention relates to the technical field of molecular diagnosis, and discloses a miRNA combination for assisting hepatic fibrosis staged screening, a kit and a use method, the miRNA combination comprises miR-216b-5p, miR-2681-5p, miR-1178-3p, miR-1323 and miR-4418, the kit is used for ddPCR detection of the content of miRNA markers in a sample, and the kit comprises a miRNA marker reverse transcription primer and a miRNA marker amplification primer. The miRNA composition provided by the invention is an ideal and reliable miRNA marker used for assisting in hepatic fibrosis staged screening, the reverse transcription primer and the amplification primer provided by the detection kit have good specificity, high sensitivity and strong specificity, and a more accurate and reliable miRNA marker concentration value can be obtained based on the ddPCR technology in combination with the kit provided by the invention.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Cryptosporidium infection early warning method based on pasture environment and oocyst detection rate analysis

PendingCN121034670AMedical data miningHealth-index calculationCryptosporidium infectionMicrobiology
The invention discloses a cryptosporidium infection early warning method based on pasture environment and oocyst detection rate analysis, which comprises the following steps: collecting pasture multi-medium environment samples and corresponding parameters, and acquiring oocyst concentration by adopting a real-time quantitative PCR (Polymerase Chain Reaction) and a molecular diagnosis model; analyzing association between the oocysts and environmental factors through an oocyst propagation and environmental dynamics model; a key environment variable weight is determined by using MaxEnt and GloWPa-Crypto algorithms, and an oocyst diffusion path is simulated; and fusing multi-dimensional data to divide risk levels, and outputting the infection risk value and duration of each region through iterative operation. According to the method, through multi-medium sampling, multi-model fusion and multi-data deep fusion, the defects of single data, inaccurate propagation process description and insufficient data fusion in the prior art are overcome, the actual infection risks of different areas of the pasture can be accurately reflected, and a precise basis is provided for prevention and control.
Owner:INST OF ANIMAL HEALTH GUANGDONG ACADEMY OF AGRI SCI

High-throughput sequencing method and system for monitoring acute lymphocytic leukemia (MRD)

The invention belongs to the technical field of tumor molecular diagnosis and biological information analysis, and relates to a high-throughput sequencing method and system for monitoring acute lymphocytic leukemia (MRD). Through targeted sequencing with a unique molecular identifier and / or a double-chain tag, error modeling based on a background noise spectrum and statistics / machine learning pseudo variation filtering, ultra-deep accurate detection of IG / TCR cloning and related gene low-frequency variation is realized. And an artificial intelligence recurrence risk prediction model is established by combining a time sequence MRD index, cloning diversity and clinical information, and a structured clinical report is output and docked with LIS / HIS. According to the method, the sensitivity and the specificity of ALL minimal residual disease detection can be remarkably improved, dynamic evaluation on leukemia cloning evolution and recurrence risks is realized, and a reliable basis is provided for individualized treatment decision and long-term follow-up visit.
Owner:SICHUAN ACADEMY OF MEDICAL SCI SICHUAN PROVINCIAL PEOPLES HOSPITAL

Detection and digital quantitation of multiple targets

The disclosure provides compositions, methods, and systems for implementation of high-performance molecular diagnostic assays involving color combinatorics, stimulus-responsive probes, tandem probes, conjugated polymer probes, and other mechanisms for increasing the number of targets that can be simultaneously detected in a digital assay. Multiplexed detection of targets is achieved in a rapid manner, with respect to sample partitioning and target detection using multiple color channels for detection.
Owner:COUNTABLE LABS INC

Fluorescence detection module, cyclic amplification detection module and small molecular diagnostic equipment

The utility model discloses a fluorescence detection module, a cyclic amplification detection module and a small molecular diagnostic device. The fluorescence detection module includes a composite driving mechanism, a mobile bracket, a detection module, a hot melt joint and a transceiver detection module. The composite driving mechanism can drive the mobile bracket to drive the detection module and the hot melt joint to alternately contact or stay away from the integrated detection consumables. When the hot melt joint contacts the integrated detection consumables, the hot melt joint seals the reaction chamber of the integrated detection consumables. The detection module is provided with a detection optical fiber. When the detection module conflicts with the integrated detection consumables, the reaction chamber is closely fitted between the external heat source and one end of the detection optical fiber. The other end of the detection optical fiber is connected to the transceiver detection module. The multi-channel transceiver unit in the transceiver detection module scans the second end of the detection optical fiber to obtain the real-time fluorescence result in the reaction chamber. The fluorescence detection module provided by the utility model realizes the reliable fixed constraint of the detection optical fiber, so that the detection result is accurate and reliable.
Owner:XIAN TIANLONG SCI & TECH

Application of PANX2 protein and mutant thereof as biopore protein

The invention belongs to the technical field of characterization of target analytes, and provides application of PANX2 protein and a mutant thereof as biopore protein. The bioporous protein is used for detecting one or more of metal ions, inorganic salts, amino acids, nucleotides, small molecule drugs, small molecule diagnostic agents, adenosine triphosphate and monosaccharides. After one or more amino acids of the wild type PANX2 protein are mutated into common amino acids except original amino acids, compared with the wild type PANX2 protein, the PANX2 protein mutant can be normally expressed and is stable in property, a current signal is obviously improved during detection, the up-down amplitude of the current signal is longer, and burrs are fewer.
Owner:JIANGXI INST OF TRANSLATIONAL MEDICINE

Recombinase polymerization amplification method based on Twinkle helicase enhancement and application thereof

ActiveCN121249857AMicrobiological testing/measurementAnnealing activityPlasmid dna
The invention relates to the field of molecular diagnosis and nucleic acid amplification, in particular to a recombinase polymerization amplification method based on Twinkle helicase enhancement and application of the recombinase polymerization amplification method. According to the invention, Twinkle helicase is introduced into an RPA system for the first time, and primer combination and template unlinking are assisted by utilizing ATP-dependent unlinking activity and DNA annealing activity of the Twinkle helicase, so that the amplification efficiency and the detection sensitivity are remarkably improved. The method is suitable for plasmid DNA, a high GC template and a clinical nucleic acid sample, and can be used for constructing an RPA kit containing Twinkle, so that the application of the RPA kit in pathogen detection, molecular diagnosis and on-site rapid detection is expanded. According to the invention, the defects of the existing RPA technology in sensitivity and stability are overcome, and a new solution is provided for developing a novel nucleic acid self-detection and field detection tool.
Owner:JILIN UNIVERSITY

A molecular diagnosis pre-processing device and a molecular diagnosis pre-processing method

The present invention relates to the field of gene detection technology, and specifically discloses a molecular diagnosis pretreatment device and a molecular diagnosis pretreatment method, in which the opening mechanism includes a clamping assembly for clamping a cover body and a tube fixing assembly for fixing a sample tube, and the clamping end of the clamping assembly can rotate relative to the tube fixing assembly around the axis of the sample tube; the pipette in the cup-dividing mechanism is used to transfer the sample in the sample tube to multiple test tubes; the extraction mechanism includes a beating assembly and an extraction assembly, and the beating sleeve in the beating assembly is slidably arranged on the frame along the axial direction of the test tube, and can reciprocate in the test tube of the extraction station; the magnetic bar in the extraction assembly is slidably arranged on the frame along the axial direction of the test tube, and can enter the beating sleeve or move out of the beating sleeve, and the transmission mechanism is used to transfer the sample tube and the test tube. The above arrangement improves the extraction effect, is not easily contaminated, and improves work efficiency.
Owner:GUANGZHOU JINQIRUI BIOTECHNOLOGY CO LTD

Detection and digital quantitation of multiple targets

The disclosure provides compositions, methods, and systems for implementation of highly multiplexed molecular diagnostic assays involving color combinatorics, stimulus-responsive probes, tandem probes, conjugated polymer probes, and other mechanisms for increasing the number of targets that can be simultaneously detected in a digital assay. Multiplexed detection of targets is achieved in a rapid manner, with respect to sample partitioning and target detection using multiple color channels for detection. Implementation of methods described also achieve detection with significantly improved signal-to-noise ratio (SNR) values.
Owner:COUNTABLE LABS INC

A molecular diagnostic device

The utility model discloses a molecular diagnostic device, and relates to the field of diagnostic devices related to small-sized amplification equipment, especially portable amplification equipment. The molecular diagnostic device provided by the utility model can make the sample liquid or sample processing liquid added into the integrated detection consumable flow between the chambers of the integrated detection consumable through the operation part, so as to obtain the amplification system liquid located in the amplification chamber. The thermal circulation part can amplify and heat the amplification system liquid in the amplification chamber, and the detection part performs fluorescence detection on the amplification system liquid in the amplification to obtain the amplification detection result. The configuration of the amplification system liquid and the amplification detection can be completed through one device, and the integration is high, the number of driving parts is small, the operation is reliable, the detection accuracy is high, and the pollution is small.
Owner:XIAN TIANLONG SCI & TECH

Feature gene screening method based on NSGA-ANN and ceRNA network construction method

The invention discloses a characteristic gene screening method based on NSGA-ANN and a ceRNA network construction method, and relates to the technical field of gastric cancer research. A public gene expression database is utilized, a non-dominated sorting genetic algorithm and a multi-layer perceptron are combined with a biostatistical method to screen key related genes of gastric cancer, a competitive endogenous RNA regulatory network is constructed, 12 key genes including SPP1, MMP13, ERBB2 and the like and a proto-oncogene regulatory pathway are found, and the screening of the key related genes of gastric cancer is realized. Wherein 11 genes can obviously influence the prognosis condition of a gastric cancer patient, and have the potential to be used as a target of target treatment or an index for early molecular diagnosis.
Owner:CHONGQING UNIV OF TECH